Talaris Therapeutics, Inc.
USD2.72
-0.02 (-0.73%)
CEO
Mary Kay Fenton
IPO Date
2021-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.78
Prev. Close
$2.74
Day Low
$2.69
Day High
$2.79
52W Low
$0.89
52W High
$3.29
Market Cap
$0.12B
Volume
0.30M
| -3.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 99.8% | -216.5% | -0.03 | 6.10 | -10.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -0.0% | -0.0% | 0.00 | 30.86 | -1839366.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -15.3% | -14.9% | 0.00 | 44.29 | -4.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -45.9% | -43.3% | 0.00 | 17.81 | -37.0 |
| -4.3 |
| 31 Dec 2024 | Q4 | 50.0% | -55587.5% | -7.4% | -7.2% | 0.00 | 30.18 | -5.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -6.3% | -6.1% | 0.00 | 40.33 | -8.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -5.2% | -5.1% | 0.00 | 46.87 | -4.7 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -3.8% | -3.7% | 0.00 | 62.17 | -10.6 |
| 31 Dec 2023 | Q4 | 50.0% | -566.9% | -6.3% | -6.1% | 0.00 | 41.76 | -8.1 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -4.9% | -4.6% | 0.00 | 18.64 | -20.4 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | 37.9% | -17.6% | -0.01 | 14.72 | -5.8 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -4.6% | -4.3% | 0.01 | 16.59 | -12.7 |